powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1194249565
Mohammed Jaloudi
MD
Hematology-Oncology
Providence,
RI
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (5)
CCN 050077
Hospital
CCN 050424
Hospital
CCN 050503
Hospital
CCN 410009
Hospital
CCN 410010
Hospital
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$6K
Payment records
60
By payment type
Consulting Fee
$4K
Food and Beverage
$1K
Top paying entities
Consulting Fee
$4K
Food and Beverage
$1K
PRESCRIBING · PART D · 2024
Total Rx claims
845
Beneficiaries
—
Total drug cost
$552K
Distinct drugs
15
Brand share
4.7%
Top prescribed drugs
Anastrozole
414 claims
Letrozole
66 claims
Tamoxifen Citrate
57 claims
Abiraterone Acetate
53 claims
Exemestane
48 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,608
Unique beneficiaries
—
Total services
30,389
Distinct HCPCS
41
Medicare payment
$504K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 46 Hematology-Oncology providers in RI — top quintile (cohort median 408).